Access to new technologies, products, talent and markets is critical for Life Sciences (LS) companies' efforts to maintain competiveness and generate growth in an environment characterized by price pressures, fast technological changes and increasingly sophisticated consumers.
Europe is especially interesting for Life Sciences companies from emerging economies and the US seeking to leverage these potential advantages. With its technological leadership and manufacturing know-how, Europe offers interesting opportunities for the acquisition or development of intellectual property (IP ) as well as the production of sophisticated products.
<p>© 2018 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. All rights reserved.</p>